‘It’s very promising’ | WashU’s experimental COVID-19 vaccine prevents disease in mice (Links to an external site)
Researchers at Washington University in St. Louis have developed a COVID-19 vaccine candidate that has prevented pneumonia in mice.
Wash U Researchers Genetically Engineer Coronavirus Lookalike (Links to an external site)
To allow more labs to conduct coronavirus research, Whelan and a team of Washington University researchers devised a workaround: a genetically engineered virus.
Lab-created virus can help COVID-19 research, developers say (Links to an external site)
A lab-created virus that’s similar to but not as dangerous as the new coronavirus could aid efforts to create COVID-19 treatments and vaccines, according to scientists who created it.
Lab-made virus mimics COVID-19 virus (Links to an external site)
Researchers at Washington University School of Medicine have developed a hybrid coronavirus that will enable more scientists to enter the fight against the pandemic. The scientists genetically modified a mild virus by swapping one of its genes for one from SARS-CoV-2, the virus that causes COVID-19.
Search for cure for common parasitic infection focus of $5.5 million NIH grant (Links to an external site)
Washington University researchers are leading an effort to to find drugs to cure toxoplasmosis, a parasitic disease characterized by vision problems and brain complications.
Whelan named head of molecular microbiology (Links to an external site)
Whelan, the Marvin A. Brennecke Distinguished Professor of Microbiology, studies how deadly viruses such as Ebola and rabies enter cells and multiply, a key step to finding targets for new antiviral drugs.
Stay informed about what’s happening in Molecular Microbiology by following us on Twitter: @WUSM_MolMicro